APA citiranje

Siller‐Matula, J. M., Specht, S., Kubica, J., Alexopoulos, D., De Caterina, R., Hobl, E., . . . Lang, I. M. (2016). Abciximab as a bridging strategy to overcome morphine–prasugrel interaction in STEMI patients. Br J Clin Pharmacol.

Citação norma Chicago

Siller‐Matula, Jolanta M., Simon Specht, Jacek Kubica, Dimitrios Alexopoulos, Raffaele De Caterina, Eva‐Luise Hobl, Bernd Jilma, Günter Christ, and Irene M. Lang. "Abciximab As a Bridging Strategy to Overcome Morphine–prasugrel Interaction in STEMI Patients." Br J Clin Pharmacol 2016.

MLA citiranje

Siller‐Matula, Jolanta M., et al. "Abciximab As a Bridging Strategy to Overcome Morphine–prasugrel Interaction in STEMI Patients." Br J Clin Pharmacol 2016.